NO931279L - Transdermal innretning - Google Patents

Transdermal innretning

Info

Publication number
NO931279L
NO931279L NO93931279A NO931279A NO931279L NO 931279 L NO931279 L NO 931279L NO 93931279 A NO93931279 A NO 93931279A NO 931279 A NO931279 A NO 931279A NO 931279 L NO931279 L NO 931279L
Authority
NO
Norway
Prior art keywords
active ingredient
pct
film
solvents
solvent mixture
Prior art date
Application number
NO93931279A
Other languages
English (en)
Other versions
NO302400B1 (no
NO931279D0 (no
Inventor
Anthony William Jenkins
Original Assignee
Ethical Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethical Pharma Ltd filed Critical Ethical Pharma Ltd
Publication of NO931279L publication Critical patent/NO931279L/no
Publication of NO931279D0 publication Critical patent/NO931279D0/no
Publication of NO302400B1 publication Critical patent/NO302400B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Surgical Instruments (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Physical Deposition Of Substances That Are Components Of Semiconductor Devices (AREA)
  • Confectionery (AREA)
NO931279A 1990-10-05 1993-04-02 Fremgangsmåte for fremstilling av en innretning for transdermal utlevering av en aktiv ingrediens NO302400B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909021674A GB9021674D0 (en) 1990-10-05 1990-10-05 Transdermal device
PCT/GB1991/001730 WO1992005811A1 (en) 1990-10-05 1991-10-04 Transdermal device

Publications (3)

Publication Number Publication Date
NO931279L true NO931279L (no) 1993-04-02
NO931279D0 NO931279D0 (no) 1993-04-02
NO302400B1 NO302400B1 (no) 1998-03-02

Family

ID=10683284

Family Applications (1)

Application Number Title Priority Date Filing Date
NO931279A NO302400B1 (no) 1990-10-05 1993-04-02 Fremgangsmåte for fremstilling av en innretning for transdermal utlevering av en aktiv ingrediens

Country Status (15)

Country Link
US (1) US5352457A (no)
EP (1) EP0551349B1 (no)
JP (1) JP2543457B2 (no)
AT (1) ATE137979T1 (no)
AU (1) AU649732B2 (no)
CA (1) CA2093321C (no)
DE (1) DE69119598T2 (no)
DK (1) DK0551349T3 (no)
ES (1) ES2090355T3 (no)
GB (2) GB9021674D0 (no)
GR (1) GR3019929T3 (no)
NO (1) NO302400B1 (no)
NZ (1) NZ240091A (no)
WO (1) WO1992005811A1 (no)
ZA (1) ZA917959B (no)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
GB9118028D0 (en) * 1991-08-21 1991-10-09 Secr Defence Brit Improved transdrmal formulations
WO1993023019A1 (en) * 1992-05-11 1993-11-25 Sri International Transdermal drug delivery systems and related compositions and methods of use
ES2115231T3 (es) * 1993-04-20 1998-06-16 Hexal Ag Emplasto con sustancias activas.
US5762952A (en) * 1993-04-27 1998-06-09 Hercon Laboratories Corporation Transdermal delivery of active drugs
US5494680A (en) * 1993-12-08 1996-02-27 Minnesota Mining And Manufacturing Company Transdermal delivery device
US5552153A (en) * 1994-04-28 1996-09-03 Hoffman-La Roche Inc. Pharmaceutical composition for transdermal delivery
US5580574A (en) * 1994-04-28 1996-12-03 Hoffmann-La Roche Inc. Pharmaceutical composition for transdermal delivery
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
DE19548332A1 (de) * 1995-12-22 1997-07-10 Rotta Res Bv Hormonpflaster
US5730721A (en) 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
DE19649535C2 (de) * 1996-11-29 2000-02-10 Lohmann Therapie Syst Lts Verfahren zur Herstellung eines pflasterförmigen therapeutischen Systems
IT1290255B1 (it) * 1997-02-05 1998-10-22 Wallcovering Pubblicita S R L Supporto sagomato aderente all'epidermide per la cessione di sostanze cosmetiche o farmacologiche e metodo per la sua fabbricazione
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
IT1294748B1 (it) 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
GB9720470D0 (en) 1997-09-25 1997-11-26 Ethical Pharmaceuticals South Inhibition of crystallization in transdermal devices
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
GB9828480D0 (en) * 1998-12-24 1999-02-17 Dermatech Limited Transdermal drug delivery system
DE19929197A1 (de) * 1999-06-25 2000-12-28 Novosis Pharma Ag Transdermalsysteme zur Abgabe von 5-HT3-Rezeptor-Antagonisten und ihre Verwendung zur antiemitischen Behandlung
DE19934523A1 (de) * 1999-07-22 2001-01-25 Novosis Pharma Ag Transdermalsysteme zur Abgabe von Muscarin-Rezeptor-Antagonisten und ihre Verwendung zur Behandlung von Spasmen der glatten Muskulatur im urologischen Bereich
US20050118247A1 (en) * 2000-07-05 2005-06-02 Gunter Cordes Method of making ketoprofen patch delivery system
US20040198706A1 (en) * 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
DE60127134T2 (de) * 2000-08-03 2007-11-08 Antares Pharma Ipl Ag Neue zusammensetzung zur transdermalen und/oder transmukosalen wirkstoffanwendung mit geeignetem therapeutischen spiegel
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
JP4358978B2 (ja) * 2000-09-05 2009-11-04 日東電工株式会社 経皮吸収製剤
NZ531789A (en) * 2001-08-17 2006-01-27 Lavipharm Lab Inc A medical device from which analgesic drugs are delivered from a drug reservoir controlled by plasticizers and adhesive matrix material
WO2004073696A1 (de) * 2003-02-21 2004-09-02 Schering Ag Uv-stabiles transdermales pflaster
BRPI0409945A (pt) 2003-04-30 2006-04-25 Purdue Pharma Lp forma de dosagem resistente à alteração
US8790689B2 (en) 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
GB0322342D0 (en) * 2003-09-23 2003-10-22 Gamble Reed Skin patch
ATE534373T1 (de) 2003-10-10 2011-12-15 Antares Pharma Ipl Ag Transdermale pharmazeutische formulierung zur minimierung von rückständen auf der haut
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
US20050202073A1 (en) * 2004-03-09 2005-09-15 Mylan Technologies, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
US20050222106A1 (en) * 2004-04-01 2005-10-06 Stefan Bracht Drospirenone-containing preparations for transdermal use
DE102004016779A1 (de) * 2004-04-01 2006-01-19 Schering Ag Drospirenonhaltige Zubereitungen zur transdermalen Anwendung
US7425340B2 (en) * 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
US8252319B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
DK2216018T3 (da) 2004-10-21 2012-07-02 Durect Corp Transdermale leveringssystemer
US8962013B2 (en) * 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
EP1926474A1 (en) * 2005-07-21 2008-06-04 Mediplex Corp. Drug formulation containing a solubilizer for enhancing solubility, absorption, and permeability
NZ571460A (en) 2006-04-21 2010-10-29 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
EP1964567A1 (de) * 2007-02-28 2008-09-03 Catriona Joos Pharmazeutische Zubereitung zur Behandlung der Migräne
US20080226698A1 (en) * 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
CA2711774C (en) 2008-01-28 2016-05-24 Teikoku Seiyaku Co., Ltd. Fentanyl-containing patch for external use
US20110182949A1 (en) * 2008-05-30 2011-07-28 Jiashang Tang Stabilized transdermal drug delivery system
US20110293757A1 (en) * 2008-07-18 2011-12-01 Novasel Australia Pty. Ltd. Compositions Comprising Tea Tree Oil and Methods for the Prevention and Treatment of Cancer
KR20110082142A (ko) 2008-10-06 2011-07-18 밀란 테크놀로지즈 인코포레이티드 비정질 로티고틴 경피 시스템
WO2012048455A1 (zh) * 2010-10-12 2012-04-19 武汉大学 一种抗病毒透皮吸收贴片及其制备方法
CN109758665B (zh) * 2019-03-13 2021-05-14 郑州佶好生物科技有限公司 一种乳康保健贴生产装置及其操作方法
US20220313565A1 (en) * 2021-04-02 2022-10-06 Jenni Mueller Broad spectrum sunblock transfer film and device

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031894A (en) * 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
IL59063A (en) * 1979-01-11 1983-12-30 Key Pharma Polymeric diffusion matrix for release of pharmaceutical dosage
JPS5843368B2 (ja) * 1980-10-30 1983-09-27 日東電工株式会社 消炎鎮痛貼付剤
JPS5984817A (ja) * 1982-11-08 1984-05-16 Sekisui Chem Co Ltd 薬剤徐放性製剤
FR2542998B1 (fr) * 1983-03-24 1986-01-31 Rhone Poulenc Sante Nouvelle forme transdermale du dinitrate d'isosorbide
DE3315272C2 (de) * 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
DE3333240A1 (de) * 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur transdermalen applikation von arzneimittelwirkstoffen
EP0156080B2 (en) * 1984-03-05 1993-10-20 Nitto Denko Corporation Percutaneous absorption type adhesive pharmaceutical preparation
US4725439A (en) * 1984-06-29 1988-02-16 Alza Corporation Transdermal drug delivery device
US4806341A (en) * 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
DE3517080A1 (de) * 1985-05-11 1986-11-13 Bayer Ag, 5090 Leverkusen Komponente fuer therapeutische wirkstoffabgabesysteme
DE3525767A1 (de) * 1985-07-19 1987-01-22 Boehringer Ingelheim Kg Pharmazeutische zubereitung mit kontrollierter und verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
DE3634016A1 (de) * 1986-04-17 1987-10-29 Lohmann Gmbh & Co Kg Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung
JPS62273159A (ja) * 1986-05-20 1987-11-27 Sumitomo Electric Ind Ltd アンチロツクシステムにおける電磁弁制御方式
JPH0699299B2 (ja) * 1986-05-23 1994-12-07 積水化学工業株式会社 経皮吸収性製剤の製造方法
JPS6393174A (ja) * 1986-10-07 1988-04-23 Nec Corp フオトダイオ−ド
JPS6393715A (ja) * 1986-10-09 1988-04-25 Sekisui Chem Co Ltd 経皮吸収貼付剤
AU601528B2 (en) * 1986-12-22 1990-09-13 Ortho-Mcneil Pharmaceutical, Inc. Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers
DE3643987A1 (de) * 1986-12-22 1988-06-23 Lohmann Therapie Syst Lts Basische, wirkstoffdurchlaessige haftklebende polymermasse, insbesondere zum einsatz mit basischen wirkstoffen, verfahren zu ihrer herstellung und ihre verwendung
CN1021196C (zh) * 1986-12-29 1993-06-16 新泽西州州立大学(鲁杰斯) 透皮雌激素/孕激素药剂单元、系统及方法
US4816258A (en) * 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
DE3878653D1 (de) * 1987-09-14 1993-04-01 Autophon Ascom Ag Telefonstation mit einem teilnehmerverzeichnis.
FR2623718B1 (fr) * 1987-11-27 1994-04-15 Fabre Medicament Pierre Dispositif therapeutique transdermique et son procede de preparation
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
GB8804164D0 (en) * 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
ATE109357T1 (de) * 1988-02-26 1994-08-15 Riker Laboratories Inc Transdermales estradiol als therapeutisches sytem.
DE3807283A1 (de) * 1988-03-05 1989-09-14 Basf Ag Verfahren zur herstellung eines pflasters zur transdermalen anwendung pharmazeutischer wirkstoffe
KR900701242A (ko) * 1988-12-01 1990-12-01 스타이너 브이. 캔스타드 에스트라디올의 경피전달용 조성물

Also Published As

Publication number Publication date
DE69119598T2 (de) 1996-09-12
AU8629591A (en) 1992-04-28
CA2093321A1 (en) 1992-04-06
GB2249956B (en) 1994-07-13
ZA917959B (en) 1992-12-30
NO302400B1 (no) 1998-03-02
GB9121135D0 (en) 1991-11-13
CA2093321C (en) 1998-11-24
ATE137979T1 (de) 1996-06-15
ES2090355T3 (es) 1996-10-16
WO1992005811A1 (en) 1992-04-16
AU649732B2 (en) 1994-06-02
DE69119598D1 (de) 1996-06-20
DK0551349T3 (da) 1996-09-30
EP0551349A1 (en) 1993-07-21
GB9021674D0 (en) 1990-11-21
NZ240091A (en) 1993-06-25
JP2543457B2 (ja) 1996-10-16
NO931279D0 (no) 1993-04-02
US5352457A (en) 1994-10-04
GB2249956A (en) 1992-05-27
EP0551349B1 (en) 1996-05-15
JPH06501932A (ja) 1994-03-03
GR3019929T3 (en) 1996-08-31

Similar Documents

Publication Publication Date Title
DK0551349T3 (da) Transdermal anordning
DK0461630T3 (da) Fremgangsmåde til fremstilling af mikrokugler
ATE240718T1 (de) Verfahren zur herstellung von arzneiformen mit kontrollierter wirkstoffabgabe auf polymerbasis
SE8403487L (sv) Farmaceutisk komposition
DK0508653T3 (da) Farmaceutisk præparat med langvarig frigivelse og fremgangsmåde til at fremstille samme
KR900007837A (ko) 퀴누클리딘, 약제로서 이의 용도 및 이의 제조방법
EP0116207A3 (en) Cosmetic formulation
ES2069814T3 (es) Composiciones de resina epoxidica que contienen poliacetoacetato.
YU49113B (sh) Postupak za dobijanje klavulanat soli
HUP0200095A2 (hu) Permetezhető kozmetikai készítmény és mátrix, amely ebben a dermálisan adagolható készítményben használható
JPS523023A (en) Preparation of amino acid ester of organopolysiloxane
ATE35620T1 (de) Pharmazeutische zubereitung mit retardwirkung.
KR880012226A (ko) 외 용 제
BE868591A (fr) Derives d'amines et d'amino-acides, leur procede d'obtention et leur utilisation notamment comme agents anti-infectieux et immunosuppresseurs
JPS5445153A (en) Polarizing film
JPS51144730A (en) An insecticide and germicide
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives
KR850001690A (ko) 조절 펩타이드를 함유하는 서방성 제제의 제조방법
JPS51133426A (en) A method for detecting activities of insecticides
SE7703040L (sv) N,n-dimetyl-o-(imidazol(5)yl)-karbaminsyraestrar till anvendning som insekticider och sett for dess framstellning
JPS5785302A (en) Wood preservative
JPS56113701A (en) Pharmaceutical preparation for injection into trunk of tree
JPS5426340A (en) Nail-polish remover
JPS5253830A (en) Preparation of optically active benzyl alcohol derivatives
KR970020101A (ko) 케토프로펜 함유 습포제용 조성물

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees